hat
Professeurs Rit Langley, anketè a chèf nan klinik inite esè Rechèch Konsèy Medikal la a nan Inivèsite Kolèj London, di: "Te gen kèk rechèch enteresan sigjere ke aspirin te kapab retade oswa sispann kansè byen bonè-etap vini tounen, men gen janm gen ankenn jijman chans bay prèv klè. jijman sa a gen pou objaktif pou reponn kesyon sa a yon fwa pou tout.
eng
Prof Ruth Langley, the chief investigator at the Medical Research Council’s clinical trials unit at University College London, said: “There has been some interesting research suggesting that aspirin could delay or stop early-stage cancers coming back, but there has been no randomised trial to give clear proof. This trial aims to answer this question once and for all.